Precision Virologics logo

Precision Virologics

Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://precisionvx.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
4041 Forrest Park Avenue, MO
Saint Louis
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]